Reliable temperature-controlled coronavirus vaccine logistics require smooth integration of all those involved as well as materials that provide good insulation.  As the range of coronavirus vaccines grows, so do the requirements for their distribution. The different vaccines need to be stored and transported at different temperature ranges – often together in the same vehicle or cold store. Handling complex processes like this is routine for leading logistics companies. But they depend on the skills of packaging providers and raw materials suppliers.

Logistics companies were already transporting pharmaceutical products at minus 70°C in boxes packed with dry ice before the coronavirus pandemic. Many of these methods are not new. The challenge for the coronavirus vaccine logistics in relation to the cooling systems is rather to adapt the known technology as quickly as possible to specific requirements such as pack sizes as well as storage and transport times.

Developed recently are passive – in other words non-electric cooling systems for the pharmaceutical industry. The lightweight thermal boxes can be fitted with special cooling elements for almost any temperature range and for different volumes. This flexibility in terms of size and cooling range comes into play with the coronavirus vaccine logistics, as three very different temperature ranges – minus 70°C, minus 15°C to minus 25°C, and plus 2°C to plus 8°C- need to be ensured.

However, there is a misconception that a higher temperature means lesser effort.  The minus 15°C to minus 25°C range may place higher demands on the packaging than minus 70°C.

Dry ice, with its temperature of minus 78°C, cannot be used in this situation, where special cooling elements are required instead.  These elements need to be cold but not too cold, so the temperature does not fall below minus 25°C but enough cooling energy still ends up in the box.

The process is invariably sophisticated in that it needs to run smoothly from the vaccine manufacturer via the packaging producer and logistics company all the way to the user of the individual vaccine doses.  Before it was practically employed, the on-purpose-developed cooling systems have already successfully undergone a demanding qualification process. They have been exposed to changing ambient temperatures in the pilot climate chambers. This ensures that the defined temperature limits are reliably maintained.

The raw materials for the pharmaceutical boxes are extremely important and need to have very good insulating properties. They are made up of expandable polystyrene (EPS) granules custom-made for the purpose.  So far, logistics service providers have already delivered tens of thousands of vaccine doses at the correct temperature in the custom-made EPS boxes. Hundreds of thousands will follow.

Reference: https://www.basf.com/global/en/media/news-releases/2021/02/p-21-126.html

More News
Energy Crisis: The EU Chemical Industry Is Reaching Breaking Point
News · 11/11/2022

The current energy crisis has reached an unsustainable level for the European chemical industry. For the first time ever, the EU imports more chemicals than it exports, both in volume and value, resulting in a trade deficit of € 5.6 bn for the first half of 2022.

READ MORE
European Union proposes to add two new hazard classes to EU CLP regulation for endocrine disruptors (EDCs)
News · 17/10/2022

Endocrine Disrupting Chemicals (also referred to as hormone disruptors or EDCs) are synthetic chemicals that are not produced by the human body and that disrupt the normal functioning of humans and animals.

READ MORE
The Shipping Industry in a downward spiral
News · 03/10/2022

The shipping industry is now returning to normality and is in a downward spiral. The cost of shipping goods from China has slumped to the lowest level in more than two years as the world economy stumbles, dimming prospects for container carriers that turned in record profits during the pandemic.

READ MORE
Global Freight Situation
News · 08/09/2022

No precipitous plunge in container shipping rates, just ‘orderly’ decline.

READ MORE
3 Key Insights into the Global Food and Beverage Market
News · 02/08/2022

The global food and beverage market size is expected to grow from $5.8 trillion in 2021 to $6.4 trillion in 2022 at a growth rate of 9.7%. The food and beverage market size is expected to grow to $8.9 trillion in 2026 at a compound annual growth rate of 8.7%.

READ MORE
NEW DRUGS (AMENDMENT) RULES,2022 MANDATES QR CODES FOR ACTIVE PHARMACEUTICAL INGREDIENTS
News · 01/07/2022

The amendment makes QR codes mandatory on every active pharmaceutical ingredient. The Amendment Rules will come into force from January 01, 2023.

READ MORE
European Green Deal
News · 01/07/2022

On June 22, 2022, the Commission adopted pioneering proposals to restore damaged ecosystems and bring nature back across Europe, from agricultural land and seas, to forests and urban environments. The Commission also proposes to reduce the use and risk of chemical pesticides by 50% by 2030.

READ MORE
Neoadjuvant Dostarlimab is a promising treatment option in locally advanced dMMR rectal cancer
News · 01/07/2022

According to New York Times, in a small clinical trial, 18 patients took a drug called Dostarlimab for around six months, and in the end, every one of them saw their tumours disappear.

READ MORE
Global recession? Not yet…
News · 02/06/2022

As the war in Ukraine and pandemic disruptions continue to wreak havoc on supply chains, stagflation is here to stay – marked by low growth and high inflation for at least the next 12 months.

The pandemic as well as the war in Ukraine have stifled supply of commodities and goods and upended efficient distribution through global supply chains, forcing up prices of everyday goods such as fuel and food.

READ MORE